Shots: The companies collaborated to develop a new AI algorithm called “basis profile curve identification.” for the improvement of brain stimulation devices to treat psychiatric illness & stroke Mayo Clinic […]readmore
Tags : Mayo Clinic
AstraZeneca Reports Results of Imfinzi (durvalumab) and Imfinzi + Tremelimumab in P-III POSEIDON Study as 1L Treatment for Stage IV Non-Small Cell Lung Cancer Published: May 7, 2021 | Tags: […]readmore
Shots: The Phenomix’s MyPhenome test utilize phenotype-driven multi-omics technology to analyze genomics, metabolomics, and hormone levels and use AI-driven algorithmic tool to identify four specific obesity phenotypes, giving doctors the […]readmore
Shots: Exact & Mayo has initiated the Voyage study to generate evidence of the real-world impact of Cologuard on colorectal cancer screening, incidence, and mortality rates. The Voyage study will […]readmore
1. Eisai And Biogen to Terminate Two P-III Clinical Studies of Elenbecestat (E2609) for Early Alzheimer’s Disease Published: Sept 13, 2019 | Tags: Eisai, Biogen, Terminate Two, P-III, Clinical Studies, Elenbecestat, […]readmore
Shots: Mayo Clinic signs 10yrs. agreement with Google to transform the future of healthcare and to hasten the pace of health care innovation via digital technologies. Google Cloud will be […]readmore